Daclatasvir Dihydrochloride and Empagliflozin and linagliptin
Determining the interaction of Daclatasvir Dihydrochloride and Empagliflozin and linagliptin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclatasvir
Brand name: Daklinza
Synonyms: Daclatasvir
Generic Name: empagliflozin / linagliptin
Brand name: Glyxambi
Synonyms: Empagliflozin and Linagliptin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclatasvir Dihydrochloride-Empagliflozin and metformin
- Daclatasvir Dihydrochloride-Empagliflozin and Metformin Extended-Release Tablets
- Daclatasvir Dihydrochloride-Empagliflozin and Metformin Tablets
- Daclatasvir Dihydrochloride-Empliciti
- Daclatasvir Dihydrochloride-Emsam
- Daclatasvir Dihydrochloride-Emsam Transdermal
- Empagliflozin and linagliptin-Daclizumab
- Empagliflozin and linagliptin-Daclizumab Subcutaneous
- Empagliflozin and linagliptin-Dacogen
- Empagliflozin and linagliptin-Dacomitinib
- Empagliflozin and linagliptin-Dactinomycin
- Empagliflozin and linagliptin-Dactinomycin Injection